Mode
Text Size
Log in / Sign up

Review: Whole-genome sequencing reveals hidden S. aureus transmission in hospitalsGenome sequencing reveals hidden S. aureus spread in hospitals

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that standard surveillance may miss many S. aureus transmission events, but universal genomic screening has unclear scalability.

This review summarizes findings from an observational study conducted in two interconnected hospitals, where whole-genome sequencing was applied to 4,779 S. aureus isolates from admission screening, clinical cultures, and serial or discharge screening. The study compared this approach to standard surveillance for detecting S. aureus transmission events.

The key finding was that whole-genome sequencing identified 361 transmission events that were undetected by standard surveillance. Notably, 90% of these events were detected only at readmission, not during the index hospitalization. Clinical isolates alone were insufficient for detection. Transmission was concentrated in methicillin-resistant strains and increased when healthcare exposure aligned with hospital-associated strain lineages.

The authors note important limitations: the practical limits of prospective whole-genome sequencing are unclear, and such approaches are unlikely to scale if applied universally. The review does not report funding or conflicts of interest.

For practice, the findings suggest that surveillance must be targeted, and serial or discharge screening is likely required to capture transmission. However, the evidence is observational, and causality cannot be inferred. Clinicians should interpret these results cautiously, recognizing the potential but also the practical constraints of genomic surveillance.

A new study used whole-genome sequencing to track how Staphylococcus aureus spreads in hospitals. Researchers analyzed nearly 4,800 S. aureus samples from patients in two interconnected hospitals. They compared what the sequencing revealed with what standard surveillance methods would have detected.

The results showed that standard surveillance missed 361 transmission events. In fact, 90% of these hidden transmissions were only spotted when patients were readmitted to the hospital. The study also found that transmission was more common with methicillin-resistant strains and when patients had more healthcare exposure.

This was a review of observational data, so it cannot prove cause and effect. The researchers note that it is unclear how practical it would be to use whole-genome sequencing in real time, and that such an approach is unlikely to be used for all patients.

For now, the findings suggest that hospitals may need to use more targeted surveillance, including screening patients when they are discharged or readmitted, to better understand and prevent the spread of S. aureus.

What this means for you:
Whole-genome sequencing can uncover hidden staph transmission, but practical limits remain for widespread use.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
In principle, whole-genome sequencing of Staphylococcus aureus in hospitals is most effective when used prospectively, but its practical limits are unclear. We performed large-scale genomic surveillance across two interconnected hospitals, sequencing 4,779 S. aureus isolates from admission screening and clinical cultures. Integration of genomic and epidemiologic data identified 361 transmission events undetected by standard surveillance. Despite dense sampling, most events (90%) were detected only at readmission, indicating that transmission escapes recognition during the index hospitalization. Serial or discharge screening is likely required to capture transmission. Detection depended on sampling: clinical isolates alone were insufficient, and nearly all events required screening and repeated sampling. Because such approaches are unlikely to scale if applied universally, surveillance must be targeted. Transmission concentrated in methicillin-resistant strains, and it increased when healthcare exposure aligned with hospital-associated strain lineage. These findings help define the limits of prospective genomic surveillance and provide a framework for targeted detection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.